Use of injectable nicardipine for neurovascular indications

Pharmacotherapy

Volumn 29, Issue 4, 2009, Pages 398-409

  Reddy, Prabashni ^a,b   Yeh, Yu Chen ^a  

^a Partners Center for Drug Policy   (United States)

^b Center for Drug Policy   (United States)

Author keywords

Hypertension; Neurovascular conditions; Nicardipine; Stroke

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; ENALAPRILAT; ESMOLOL; GLYCERYL TRINITRATE; HYDRALAZINE; LABETALOL; NICARDIPINE; NITROPRUSSIDE SODIUM;

ANESTHETIC RECOVERY; ANGINA PECTORIS; ANOREXIA; ARTERY DIAMETER; ARTICLE; BLOOD PRESSURE REGULATION; BRADYCARDIA; BRAIN ARTERY ANEURYSM; BRAIN CIRCULATION; BRAIN HEMORRHAGE; BRAIN INFECTION; BRAIN ISCHEMIA; BRAIN VASOSPASM; BRONCHOSPASM; CRANIOTOMY; DIAGNOSTIC IMAGING; DIARRHEA; DIZZINESS; DOPPLER ECHOGRAPHY; DRUG COST; DRUG DOSE TITRATION; DRUG ERUPTION; DRUG RESEARCH; EXFOLIATIVE DERMATITIS; FLUSHING; GLASGOW COMA SCALE; HEADACHE; HEART BLOCK; HEART PALPITATION; HUMAN; HYDROCEPHALUS; HYPOTENSION; INJECTION SITE PAIN; INTRACRANIAL HYPERTENSION; LOADING DRUG DOSE; LUNG EDEMA; MEAN ARTERIAL PRESSURE; MEDICAL EXPERT; MENINGITIS; MUSCLE SPASM; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NAUSEA; PHLEBITIS; PRACTICE GUIDELINE; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SCALP PRURITUS; SIDE EFFECT; SPINE SURGERY; STROKE; SUBARACHNOID HEMORRHAGE; SWEATING; SYNCOPE; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; TACHYPHYLAXIS; THERAPY EFFECT; THROMBOEMBOLISM; TRAUMATIC BRAIN INJURY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VOMITING;

ANTIHYPERTENSIVE AGENTS; CEREBRAL HEMORRHAGE; HUMANS; HYPERTENSION; INJECTIONS; META-ANALYSIS AS TOPIC; NICARDIPINE; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; STROKE; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 64849099232     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.29.4.398     Document Type: Article

References (29)

1. Adams HP, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke. Stroke 2007;38:1655-711. (Errata in Stroke 2007;38:e38 and Stroke 2007;38:e96.)
2. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update. Stroke 2007;38:2001-23.
3. Badjatia N, Topcuoglu MA, Pryor JC, et al. Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. AJNR Am J Neuroradiol 2004;25:819-26.
4. Tejada JG, Taylor RA, Ugurel MS, Hayakawa M, Lee SK, Chaloupka JC. Safety and feasibility of intra-arterial nicardipine for the treatment of subarachnoid hemorrhageassociated vasospasm: initial clinical experience with high-dose infusions. AJNR Am J Neuroradiol 2007;28:844-8.
5. PDL BioPharma, Inc. Cardene IV (nicardipine) prescribing information. Fremont, CA; 2006.
6. PDR Staff, eds. Red book: pharmacy's fundamental reference. Montvale, NJ: Thomson, 2007.
7. Merck & Co., Inc. Vasotec IV (enalaprilat) prescribing information. Whitehouse Station, NJ; 2000.
8. Marik PE, Varon J. Hypertensive crises: challenges and management. Chest 2007;131:1949-62.
9. Baxter Healthcare Corporation. Brevibloc (esmolol) prescribing information. Bridgewater, NJ; 2005.
10. American Society of Health-System Pharmacists. Hydralazine (systemic). Available from http://www.ashp.org/mngrphs/essentials/a382246e.htm. Accessed January 26, 2009.
11. Elliott HL, Meredith PA, Sumner DJ, Reid JL. Comparison of the clinical pharmacokinetics and concentration-effect relationships for medroxalol and labetalol. Br J Clin Pharmacol 1984;17:573-8.
12. Parke-Davis. Nitrostat (nitroglycerin) prescribing information. Morris Plains, NJ; 1999.
13. Roche US. Nipride (nitroprusside) prescribing information. Nutley NJ; 1990.
14. Qureshi AI. Acute hypertensive response in patients with stroke: pathophysiology and management. Circulation 2008;118:176-87.
15. Dorhout Mees SM, Rinkel GJE, Feigin VL, et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2007;(3):CD000277.
16. Langham J, Goldfrad C, Teasdale G, Shaw D, Rowan K. Calcium channel blockers for acute traumatic brain injury. Cochrane Database Syst Rev 2003;(4):CD000565.
17. Brisman JL, Eskridge JM, Newell DW. Neurointerventional treatment of vasospasm. Neurol Res 2006;28:769-76.
18. Powers WJ, Zazulia AR, Videen TO, et al. Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage. Neurology 2001;57:18-24.
19. Abe K, Iwanga H, Inada E. Effect of nicardipine and diltiazem on internal carotid artery blood flow velocity with local cerebral blood flow during cerebral aneurysm surgery for subarachnoid hemorrhage. J Clin Anesth 1994;6:99-105.
20. Kross RA, Ferri E, Leung D, et al. A comparative study between a calcium channel blocker (nicardipine) and a combined α-β-blocker (labetalol) for the control of emergence hypertension during craniotomy for tumor surgery. Anesth Analg 2000;91:904-9.
21. Bernard JM, Passuti N, Pinaud M. Long-term hypotensive technique with nicardipine and nitroprusside during isoflurane anesthesia for spinal surgery. Anesth Analg 1992;75:179-85.
22. Haley EC, Kassell NF, Torner JC. A randomized trial of nicardipine in subarachnoid hemorrhage: angiographic and transcranial Doppler ultrasound results. J Neurosurg 1993;78:548-53.
23. Haley EC, Kassell NF, Torner JC. A randomized controlled trial of high-dose intravenous nicardipine in aneurismal subarachnoid hemorrhage. J Neurosurg 1993;78:537-47.
24. Avitsian R, Fiorella D, Soliman MM, Mascha E. Anesthetic considerations of selective intra-arterial nicardipine injection for intracranial vasospasm: a case series. J Neurosurg Anesthesiol 2007;19:125-9.
25. Suzuki M, Doi M, Otawara Y, Ogasawara K, Ogawa A. Intrathecal administration of nicardipine hydrochloride to prevent vasospasm in patients with subarachnoid hemorrhage. Neurosurg Rev 2001;24:180-4.
26. Shibuya M, Suzuki Y, Enomoto H, Okada T, Ogura K, Sugita K. Effects of prophylactic intrathecal administrations of nicardipine on vasospasm in patients with severe aneurysmal subarachnoid haemorrhage. Acta Neurochir 1994;131:19-25.
27. Flamm ES, Adams HP, Beck DW, et al. Dose-escalation study of intravenous nicardipine in patients with aneurismal subarachnoid hemorrhage. J Neurosurg 1988;68:393-400.
28. U.S. National Institutes of Health. ClinicalTrials.gov. Available from http://www.clinicaltrials.gov/. Accessed October 22, 2008.
29. Barth M, Cappelle HH, Weidauer S, et al. Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcomes after severe aneurysmal subarachnoid hemorrhage. Stroke 2007;38:330-6.